Rybrila 160 micrograms / ml Oral Solution

Licence status
Withdrawn: 31/05/2024
Active substances
Glycopyrronium bromide
Dosage Form
Oral solution
Licence number
PA22701/001/001
Licence holder
Clinigen Healthcare B.V.

Product documents

Licence information

ATC code
A03AB02 glycopyrronium bromide
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2). Rybrila should be prescribed by physicians experienced in the treatment of paediatric patients with neurological disorders.
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
23/07/2021

Educational materials for healthcare professionals

Educational materials for patients